|
Using tumor genomic profile testing and comorbidity level to personalize chemotherapy decisions among older patients with early-stage breast cancer. |
|
|
No Relationships to Disclose |
|
|
Honoraria - AstraZeneca; Genentech/Roche; Pfizer |
Consulting or Advisory Role - AstraZeneca; Genentech/Roche; Medivation; NanoString Technologies; Novartis; Pfizer; Syndax |
Speakers' Bureau - AstraZeneca; Genentech; Pfizer |
Research Funding - Genentech (Inst); Novartis (Inst); Pfizer (Inst); Pfizer (Inst); Tesaro (Inst) |
Patents, Royalties, Other Intellectual Property - McGraw Hill Publishing; UpToDate |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |